Feature Channels: Personalized Medicine

Filters close
Released: 1-Jun-2020 9:00 AM EDT
First-of-its-Kind Personalized 'COVID-19 Risk Score' Launches to Enable Safer Re-opening and Return to Work Plans
Coriell Life Sciences

Coriell Life Sciences is rolling out a new tool in the fight against COVID-19: personalized COVID-19 Risk Scores designed to enable safer re-opening and return to work plans (especially given the recent release of the CDC guidelines for re-opening).

Newswise: Precision medicine guides choice of better drug therapy in severe heart disease
Released: 14-May-2020 4:45 PM EDT
Precision medicine guides choice of better drug therapy in severe heart disease
University of Alabama at Birmingham

Is personalized medicine cost-effective? Researchers have answered that question for one medical treatment, genotype-guided antiplatelet therapy for acute coronary syndrome patients with PCI. Their study uses pharmacogenomics and economic analysis of real-world clinical data.

Released: 14-May-2020 4:25 PM EDT
New CAP Guideline Improves Collection, Handling of Lung Specimens
College of American Pathologists (CAP)

The College of American Pathologists (CAP) released a new evidence- based guideline “Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies” to clarify procedures and methods to optimize test outcomes.

Newswise: Genetic complexity: A spanner in the works?
Released: 4-May-2020 1:15 PM EDT
Genetic complexity: A spanner in the works?
McMaster University

The promise of personalized medicine has not fully materialized, say two McMaster researchers, because the full sophistication of the genetic blueprint has a more complex and far-reaching influence on human health than scientists had first realized.

Newswise: Cedars-Sinai Looks to Space for Tomorrow's Stem Cell Therapies
Released: 17-Apr-2020 9:00 AM EDT
Cedars-Sinai Looks to Space for Tomorrow's Stem Cell Therapies
Cedars-Sinai

Is the future of personalized medicine out of this world? Cedars-Sinai is trying to find out by launching special stem cells into space to see if they multiply better there. The Cedars-Sinai Board of Governors Regenerative Medicine Institute is partnering with Space Tango of Lexington, Kentucky, to send induced pluripotent stem cells (iPSCs) to the International Space Station. The first flight for the project, funded by a $1.5 million award from NASA, could occur as early as next year.

Newswise: The pros and cons of radiotherapy: will it work for you?
Released: 30-Mar-2020 8:45 AM EDT
The pros and cons of radiotherapy: will it work for you?
University of South Australia

Women undergoing radiotherapy for many cancers are more likely than men to be cured, but the side effects are more brutal, according to one of Australia’s most experienced radiation oncology medical physicists.

Newswise: April's Edition of SLAS Technology is Accessible
Released: 23-Mar-2020 11:35 AM EDT
April's Edition of SLAS Technology is Accessible
SLAS

Just released is the April edition of SLAS Technology featuring cover article, “CURATE.AI: Optimizing Personalized Medicine with Artificial Intelligence,” by Agata Blasiak, Ph.D., Jeffrey Khong, Ph.D., and Theodore Kee, Ph.D., (University of Singapore and The N.1 Institute for Health).

Released: 21-Feb-2020 8:00 AM EST
Coriell Researchers Identify SNP Associated with Obesity Risk
Coriell Institute for Medical Research

Obesity is among the most common complex diseases in the United States and has been a stubborn public health challenge for decades. Its causes are wide ranging, but genetic heritability is increasingly understood to be an influential factor in determining a person’s risk for the disease. Coriell researchers have found a new genetic indicator of obesity risk and bolstered the understood importance of one gene’s role in obesity risk.

Newswise: John Theurer Cancer Center Launches Clinical Trial of Personalized Cancer Vaccine Using New Gene-Based Technology for High-Risk Melanoma
Released: 20-Feb-2020 10:55 AM EST
John Theurer Cancer Center Launches Clinical Trial of Personalized Cancer Vaccine Using New Gene-Based Technology for High-Risk Melanoma
Hackensack Meridian Health

John Theurer Cancer Center at Hackensack University Medical Center is the only site in New Jersey and one of just 17 in the country participating in a multicenter international Phase II study of an innovative personalized cancer vaccine being evaluated in combination with pembrolizumab immunotherapy in patients with melanoma that has been surgically removed but has a high risk of coming back. The hope is that the vaccine can prime a patient's immune system to be more responsive to immunotherapy and reduce the risk of cancer recurrence.

Newswise: 224618_web.jpg
Released: 19-Feb-2020 11:15 AM EST
Think all BPA-free products are safe? Not so fast, scientists warn
University of Missouri, Columbia

Using "BPA-free" plastic products could be as harmful to human health -- including a developing brain -- as those products that contain the controversial chemical, suggest scientists in a new study led by the University of Missouri and published in the Proceedings of the National Academy of Sciences.

Newswise: Superior “Bio-Ink” for 3D Printing Pioneered
Released: 10-Feb-2020 2:05 PM EST
Superior “Bio-Ink” for 3D Printing Pioneered
Rutgers University-New Brunswick

Rutgers biomedical engineers have developed a “bio-ink” for 3D printed materials that could serve as scaffolds for growing human tissues to repair or replace damaged ones in the body. Their study was published in the journal Biointerphases.

Released: 4-Feb-2020 4:15 PM EST
A New Outline of Cancer Therapies for Patients
American Technion Society

Professor Yuval Shaked, head of the Technion Integrated Cancer Center, presents an outline for therapy that will prevent the development of cancer treatment resistance, with suggestions about how the information can be used clinically.

Newswise: Grant to help UniSA researchers develop personalised cancer treatment
Released: 12-Jan-2020 9:05 AM EST
Grant to help UniSA researchers develop personalised cancer treatment
University of South Australia

Personalised cancer treatment is one step closer to becoming a reality for more patients, thanks to a Cancer Council Beat Cancer Project grant awarded to University of South Australia researcher Dr Stephanie Reuter Lange to explore how computer-based modelling can optimise cancer treatment and remove the need for expensive clinical trials.

Released: 10-Jan-2020 2:25 PM EST
Your Brain: Individual and Unique
American Technion Society

New findings show that individual variations in the brain’s structural connectome (map of neural connections) define a specific structural fingerprint with a direct impact on the functional organization of individual brains.

6-Jan-2020 11:00 AM EST
Mayo Clinic to sequence 100K participants to build genomic database for improved care and research in collaboration with Helix
Mayo Clinic

Mayo Clinic is creating a library of genomic sequencing data on 100,000 consented Mayo Clinic participants to advance research and patient care.

Newswise: Fred Hutch names Dr. Thomas J. Lynch Jr. as new president and director
Released: 7-Jan-2020 11:35 AM EST
Fred Hutch names Dr. Thomas J. Lynch Jr. as new president and director
Fred Hutchinson Cancer Research Center

Fred Hutchinson Cancer Research Center announced today that Dr. Thomas J. Lynch Jr. will become the center’s new president and director. Lynch, a well-known cancer leader with expertise in solid tumor research, precision medicine and immuno-oncology, will join Fred Hutch Feb. 1.

Released: 24-Dec-2019 10:20 AM EST
Researchers Probe Emerging Mesothelioma Treatment Targeting PP2A and CDK
Sbarro Health Research Organization (SHRO)

A collaborative study of researchers from Thomas Jefferson University, Sbarro Institute for Cancer Research and Molecular Medicine of Temple University, University of Siena, and from the Spanish Center for the Applied Medical Research (CIMA) of the University of Navarra have discovered a novel targetable axis in mesothelioma patients.

Released: 11-Dec-2019 3:35 PM EST
VUMC’s Denny Selected to Lead National ‘All of Us’ Program
Vanderbilt University Medical Center

The National Institutes of Health (NIH) has selected Joshua C. Denny, MD, MS, vice president of Personalized Medicine at Vanderbilt University Medical Center (VUMC), to be the Chief Executive Officer of the federal All of Us Research Program.

Newswise: Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine
Released: 4-Dec-2019 8:40 AM EST
Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine
National Comprehensive Cancer Network® (NCCN®)

NCCN Guidelines for Genetic/Familial Risk Assessment: Breast, Ovarian, and Pancreatic updated with new and expanded sections on risk assessment and management related to three major cancer types.

Newswise: Ge Wang Named a Fellow of the National Academy of Inventors
Released: 3-Dec-2019 12:20 PM EST
Ge Wang Named a Fellow of the National Academy of Inventors
Rensselaer Polytechnic Institute (RPI)

Ge Wang, the Clark and Crossan Endowed Chair of biomedical engineering and director of the Biomedical Imaging Center at Rensselaer Polytechnic Institute, has been named a fellow of the National Academy of Inventors (NAI).

Newswise: FAU Schmidt College of Medicine Launches 
Genomics and Predictive Health Certificate
Released: 21-Nov-2019 9:00 AM EST
FAU Schmidt College of Medicine Launches Genomics and Predictive Health Certificate
Florida Atlantic University

The lack of understanding of health providers and patients is a major barrier to the integration of genomics into personalized medicine. This innovative certificate program will provide health professionals and scientists with the requisite skills they need to interpret and incorporate this new knowledge into a patient care model that emphasizes individually tailored prevention, diagnosis and treatment.

Newswise: Researchers identify new gene mutation in familial thyroid cancers
Released: 20-Nov-2019 9:00 AM EST
Researchers identify new gene mutation in familial thyroid cancers
Penn State College of Medicine

Researchers from Penn State College of Medicine identified a new gene mutation that may cause a type of familial thyroid cancer.

Newswise: Science in Action: Wellness in the Workplace with Genetic Testing
Released: 19-Nov-2019 12:45 PM EST
Science in Action: Wellness in the Workplace with Genetic Testing
Coriell Life Sciences

The cost of genetic testing has steadily declined since the human genome was first mapped in 2003, allowing large employers, healthcare systems, and pension funds to adopt an upstream approach to preventative care by offering genetic testing and precision medicine as proactive wellness benefits.

Newswise: Can ‘smart toilets’ be the next health data wellspring?
Released: 13-Nov-2019 10:40 AM EST
Can ‘smart toilets’ be the next health data wellspring?
Morgridge Institute for Research

Wearable, smart technologies are transforming the ability to monitor and improve health, but a decidedly low-tech commodity — the humble toilet — may have potential to outperform them all.

Released: 8-Nov-2019 10:30 AM EST
Approach to Personalizing Treatment of Triple-Negative Breast Cancer Shows Promise in Cell Lines
Michigan Medicine - University of Michigan

A group of researchers at the University of Michigan Rogel Cancer Center is laying the foundations for a new, “multi-omic” approach that could help determine the drugs to which a particular triple-negative tumor will be most likely to respond based on the totality of its molecular features.

Newswise: Potential Genetic Markers of Multiple Sclerosis Severity
Released: 31-Oct-2019 8:00 AM EDT
Potential Genetic Markers of Multiple Sclerosis Severity
Johns Hopkins Medicine

In a bid to determine factors linked to the most debilitating forms of multiple sclerosis (MS), Johns Hopkins Medicine researchers say they have identified three so-called “complement system” genes that appear to play a role in MS-caused vision loss. The researchers were able to single out these genes — known to be integral in the development of the brain and immune systems — by using DNA from MS patients along with high-tech retinal scanning.

24-Oct-2019 2:30 PM EDT
Cleveland Clinic Study Finds Functional Medicine Model is Associated with Improvements in Health-Related Quality of Life
Cleveland Clinic

In the first retrospective cohort study of the functional medicine model, Cleveland Clinic researchers found that functional medicine was associated with improvements in health-related quality of life. The study was published today in the Journal of the American Medical Association Network Open.

Newswise: Bacterial Lifestyle Steers the Evolution of Antibiotic Resistance
Released: 23-Oct-2019 10:00 AM EDT
Bacterial Lifestyle Steers the Evolution of Antibiotic Resistance
Health Sciences at the University of Pittsburgh

How bacteria live – whether as independent cells or in a communal biofilm – determines the course of their evolution, with implications for drug-resistant infections.

14-Oct-2019 8:00 AM EDT
If your health care provider is nice, you’ll feel less pain
American Society of Anesthesiologists (ASA)

Having blood drawn by a courteous health care provider can really take the sting out of those procedures, suggests a study being presented at the ANESTHESIOLOGY® 2019 annual meeting.

Newswise: New Precision Immunotherapy Clinic Matches Patients to Latest Cancer Therapies
Released: 17-Oct-2019 3:50 PM EDT
New Precision Immunotherapy Clinic Matches Patients to Latest Cancer Therapies
University of California San Diego Health

New Precision Immunotherapy Therapy clinic at Moores Cancer Center at UC San Diego Health matches patients using genetic profiling to personalized cancer treatment plans.

Newswise: Ludwig Researchers Develop Machine Learning Tool to Refine Personalized Immunotherapy
Released: 14-Oct-2019 12:00 PM EDT
Ludwig Researchers Develop Machine Learning Tool to Refine Personalized Immunotherapy
Ludwig Cancer Research

Ludwig Cancer Research scientists have developed a new and more accurate method to identify the molecular signs of cancer likely to be presented to helper T cells, which stimulate and orchestrate the immune response to tumors and infectious agents.

Newswise: The University of Chicago Medicine to Honor Breast Cancer Specialist Laura Esserman
Released: 14-Oct-2019 11:05 AM EDT
The University of Chicago Medicine to Honor Breast Cancer Specialist Laura Esserman
University of Chicago

Breast cancer specialist Laura Esserman, MD, MBA, is being honored for excellence in the field of cancer research with an award from the University of Chicago Medicine Comprehensive Cancer Center.

Newswise: October’s SLAS Technology Special Issue Published
Released: 11-Oct-2019 3:05 PM EDT
October’s SLAS Technology Special Issue Published
SLAS

In the October Special Issue of SLAS Technology, Guest Editors Soojung Claire Hur, Ph.D., and Deok-Ho Kim, Ph.D., (Johns Hopkins University; Baltimore, MD, USA) introduce a collection of articles and reviews focused on the advancement in technologies that are playing a major role in shifting healthcare closer to more predictive, preventative and personalized medicine.

Newswise:Video Embedded iu-school-of-medicine-awarded-36-million-nih-grant-for-alzheimer-s-disease-drug-discovery-center
VIDEO
27-Sep-2019 12:05 AM EDT
IU School of Medicine awarded $36 million NIH grant for Alzheimer's disease drug discovery center
Indiana University

The IU-led center is one of only two multi-institution teams in the nation selected as part of a new federal program intended to improve, diversify and reinvigorate the Alzheimer's disease drug development pipeline.

Newswise: Rutgers Cardiologist Advocates for Personalized Treatment with Aspirin as Primary Prevention in Cardiovascular Disease
Released: 17-Sep-2019 10:05 AM EDT
Rutgers Cardiologist Advocates for Personalized Treatment with Aspirin as Primary Prevention in Cardiovascular Disease
Rutgers Robert Wood Johnson Medical School

A nationally recognized Rutgers cardiologist recommends that aspirin be used as primary prevention for cardiovascular disease only with select patients, saying that the scientific evidence is too diverse to support a one-size-fits-all approach.

Newswise: Cancer Protocols: A New Approach to Predicting Treatment Outcomes
Released: 13-Sep-2019 1:45 PM EDT
Cancer Protocols: A New Approach to Predicting Treatment Outcomes
Weizmann Institute of Science

Research by the Weizmann Institute of Science's Prof. Yardena Samuels shows that heterogeneity in melanoma tumors prevents effective immune responses

22-Aug-2019 2:05 PM EDT
Drug Resistance Signature Discovered in Crohn’s Disease
Mount Sinai Health System

Finding May Create Opportunity to Test Patients to Avoid Ineffective Drugs

Released: 22-Aug-2019 10:50 AM EDT
Moffitt Researchers Develop Model to Personalize Radiation Treatment for Breast Cancer Patients
Moffitt Cancer Center

A personalized approach to cancer treatment has become more common over the last several decades, with numerous targeted drugs approved to treat particular tumor types with specific mutations or patterns. However, this same personalized strategy has not translated to radiation therapy, and a one-size-fits-all approach for most patients is still common practice. Moffitt Cancer Center researchers hope to change this mindset for radiation treatment with the development of a genomically-based model that can optimize and personalize a radiation dose to match an individual patient’s needs.

Newswise: Adding MS Drug to Targeted Cancer Therapy May Improve Glioblastoma Outcomes
Released: 8-Aug-2019 4:50 PM EDT
Adding MS Drug to Targeted Cancer Therapy May Improve Glioblastoma Outcomes
University of California San Diego Health

The multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice by reaching stem cells at the tumor’s root, according to a new UC San Diego School of Medicine study published in Science Translational Medicine.

22-Jul-2019 8:55 AM EDT
Experts to Demystify Direct-to-Consumer Genetic Testing at the 71st AACC Annual Scientific Meeting
American Association for Clinical Chemistry (AACC)

On August 4, a special session at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo will shed much-needed light on the nuances of direct-to-consumer genetic testing.

Released: 30-Jul-2019 9:00 AM EDT
CHOP Research Team Redefines the Footprint of Viral Vector Gene Therapy
Children's Hospital of Philadelphia

Building on a track record of developing adeno-associated viral (AAV) vectors as a groundbreaking clinical tool for gene therapy and gene editing, Children’s Hospital of Philadelphia (CHOP) researchers report a more sensitive method for capturing the footprint of AAV vectors—a broad range of sites where the vectors transfer genetic material.

Newswise: Pediatricians first in the field to assess how to personalize treatment for hypertension in children
Released: 26-Jul-2019 8:05 AM EDT
Pediatricians first in the field to assess how to personalize treatment for hypertension in children
University of Texas Health Science Center at Houston

High blood pressure among children is on the rise and a lack of research about how to treat it has left pediatricians trying to make their best guess. That’s until researchers released results of a pioneering study that used a series of personalized trials to identify a preferred therapy for kids – the first step in tackling the problem.

Newswise:Video Embedded expanding-the-limits-of-personalized-medicine-with-high-performance-computing
VIDEO
Released: 24-Jul-2019 5:05 PM EDT
Expanding the limits of personalized medicine with high-performance computing
Argonne National Laboratory

Imagine that you have a serious medical condition. Then imagine that when you visit a team of doctors, they could build an identical virtual ‘twin’ of the condition and simulate millions of ways to treat it until they develop an effective treatment. That is the vision of a team of scientists, led by Argonne National Laboratory.

Newswise: New technique helps create more personalized therapies for people with hard-to-treat cancers
18-Jul-2019 3:05 PM EDT
New technique helps create more personalized therapies for people with hard-to-treat cancers
University of California, Los Angeles (UCLA), Health Sciences

Using an ultra-sensitive and high-throughput isolation technology, UCLA researchers were able to characterize and identify the neoantigens driving the antitumor responses in a patient treated with anti-PD-1 blockade and isolate the T cell receptors responsible for such effect.

Newswise: Tulane University Names Leading Developer of Advanced Biomedical Diagnostics Newest Presidential Chair
Released: 16-Jul-2019 7:00 AM EDT
Tulane University Names Leading Developer of Advanced Biomedical Diagnostics Newest Presidential Chair
Tulane University

Tulane University has named research scientist Tony Hu, PhD, a pioneer in developing advanced diagnostics for personalized medicine, as its second endowed presidential chair.

Released: 8-Jul-2019 4:05 PM EDT
Augustana University Professor’s Research Leads to Surprising Mating Decision in Butterfly Species
Augustana University, South Dakota

The males of one species of butterfly are more attracted to females that are active, not necessarily what they look like, according to a recent research conducted at Augustana University.The paper, “Behaviour before beauty: Signal weighting during mate selection in the butterfly Papilio polytes,” found that males of the species noticed the activity levels of potential female mates, not their markings.

Newswise: Mutation Discovery Leads to Precise Treatment for Child with Severe Lymphatic Disorder
27-Jun-2019 4:50 PM EDT
Mutation Discovery Leads to Precise Treatment for Child with Severe Lymphatic Disorder
Children's Hospital of Philadelphia

Faced with a preteen boy who had painful swelling and respiratory distress from a severe, deteriorating rare condition, researchers at Children’s Hospital of Philadelphia identified the responsible gene mutation and harnessed that knowledge to develop a novel treatment that dramatically improved the problem.

Newswise: Personalized Medicine Software Vulnerability Uncovered by Sandia Researchers
Released: 1-Jul-2019 10:05 AM EDT
Personalized Medicine Software Vulnerability Uncovered by Sandia Researchers
Sandia National Laboratories

A weakness in one common open source software for genomic analysis left DNA-based medical diagnostics vulnerable to cyberattacks. Researchers at Sandia National Laboratories identified the weakness and notified the software developers, who issued a patch to fix the problem. The issue has also been fixed in the latest release of the software.

Released: 17-Jun-2019 4:05 PM EDT
UCSF Names First-Ever Chief Biobank Officer
UCSF Helen Diller Family Comprehensive Cancer Center

Signaling its continued commitment to pioneering research, UC San Francisco has appointed Rohit Gupta as its inaugural Chief Biobank Officer (CBO). His appointment, which follows a national search, is effective June 19.


Showing results

150 of 565

close
1.73026